Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- KDGEVBNRKBL5
- Grand Hotel Inter Continental Paris · Paris, IDF NZP7GZN2TBM7
- Singapore KZGWU4FU9UK5
- KC2HHE2LH3H3
- Singapore TZKJJ1YLKML6
- NEP9PKNU3LD8
- Singapore N3KJLATBBL26
- Reston, VA F7UXBNKG25K9
-
- SAM.gov registration date
- Physical address
- 10 Hospital Blvd, Singapore 168582
- Website
- nccs.com.sg
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Children's Hospital Of Philadelphia | R01AR079822 | $180,718 |
Similar vendors
About the company
National Cancer Centre Of Singapore PTE LTD is a corporate entity registered to receive awards from the U.S. federal government since August 10, 2011. As a non-profit organization and hospital, it provides specialized medical services and conducts research in the field of oncology. The center collaborates with various U.S. institutions and agencies to contribute to advancements in cancer research and treatment. Through its federal contract and grant awards, National Cancer Centre Of Singapore PTE LTD offers expertise in biomedical research, clinical trials, and specialized laboratory services.
While the provided information does not include specific details about federal contract awards for National Cancer Centre Of Singapore PTE LTD, it is registered as eligible to receive such awards. As a hospital and research institution, it is likely that any contract awards would be related to medical research, clinical trials, or specialized laboratory services in the field of oncology. These contracts could potentially involve collaborations with U.S. government agencies such as the National Institutes of Health (NIH) or the National Cancer Institute (NCI).
The federal grant sub-awards received by National Cancer Centre Of Singapore PTE LTD demonstrate its involvement in significant research projects. One such project, in collaboration with The Children's Hospital of Philadelphia, focuses on testing the association of serologic biomarkers with medication withdrawal and subsequent risk of flare in children. This research involves evaluating differences in cytokine and messenger RNA expression in children who experience disease flare versus those who maintain disease quiescence. Dr. Salvatore Albani, a co-investigator at SingHealth, leads the center's efforts in performing CyTOF analyses on children enrolled in the parent trial. This project showcases the center's expertise in advanced laboratory techniques and its contribution to pediatric medical research. Additionally, through its subsidiary, Singapore General Hospital PTE LTD, the organization is involved in a project aimed at improving local detection of head and neck cancer in low-resource settings. This study, in collaboration with Duke University, focuses on implementing a novel low-cost flexible nasolaryngoscope in Vietnam, potentially serving as a model for integrating this technology into head and neck cancer care in other low-resource settings.
Quick answers
Is National Cancer Centre Of Singapore PTE LTD registered in SAM.gov?
Yes. National Cancer Centre Of Singapore PTE LTD's SAM.gov registration is active through July 5, 2027.
What is National Cancer Centre Of Singapore PTE LTD's CAGE code?
National Cancer Centre Of Singapore PTE LTD's CAGE code is QC370, and its Unique Entity ID (UEI) is EUKJBSS2CEH3.
On GovTribe
See National Cancer Centre Of Singapore PTE LTD's full federal record
- Similar vendors